CN116769154A - Preparation method of monomethoxy polyethylene glycol sulfhydryl - Google Patents

Preparation method of monomethoxy polyethylene glycol sulfhydryl Download PDF

Info

Publication number
CN116769154A
CN116769154A CN202310822761.4A CN202310822761A CN116769154A CN 116769154 A CN116769154 A CN 116769154A CN 202310822761 A CN202310822761 A CN 202310822761A CN 116769154 A CN116769154 A CN 116769154A
Authority
CN
China
Prior art keywords
polyethylene glycol
mpeg
monomethoxy polyethylene
preparing
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310822761.4A
Other languages
Chinese (zh)
Inventor
李宁
邵每
申晓阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siping Oukai Technology Co ltd
Original Assignee
Siping Oukai Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siping Oukai Technology Co ltd filed Critical Siping Oukai Technology Co ltd
Priority to CN202310822761.4A priority Critical patent/CN116769154A/en
Publication of CN116769154A publication Critical patent/CN116769154A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3348Polymers modified by chemical after-treatment with organic compounds containing sulfur containing nitrogen in addition to sulfur
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a preparation method of monomethoxy polyethylene glycol mercapto, belonging to the technical field of compound synthesis methods. Mixing cystamine hydrochloride, triethylamine and mPEG-SCM for reaction to obtain an SH intermediate; and then adding tri (2-carboxyethyl) phosphine, SH intermediate and 2, 6-di-tert-butyl-p-cresol into the buffer solution to react so as to obtain the monomethoxy polyethylene glycol mercapto. The intermediate preparation of the invention is added with excessive cystamine hydrochloride, so the conversion rate of mPEG-SCM can be close to 100%, meanwhile, TCEP is selected as a disulfide bond cutting agent, the TECP has stronger reducing capability and selectivity, and compared with the existing DTT, the method has smaller and safer toxic and side effects on human bodies.

Description

Preparation method of monomethoxy polyethylene glycol sulfhydryl
Technical Field
The invention belongs to the technical field of compound synthesis methods, and particularly relates to a preparation method of monomethoxy polyethylene glycol mercapto.
Background
The existing method for preparing the monomethoxy polyethylene glycol sulfhydryl group comprises the following specific steps:
the first step: the intermediate connecting the two ends was prepared using mPEG-SCM (monomethoxy polyethylene glycol succinimidyl acetate) with cystamine hydrochloride in DCM (dichloromethane) as solvent under triethylamine conditions, the reaction procedure was as follows:
the yields of such intermediates prepared are known from the prior art (U.S. Pat. No. 3,182A) to be about 98%;
and a second step of: cleavage with TCEP, DTT, mercaptoethanol, etc
The method requires strict control of the molar quantity ratio of the feed in the preparation process of the first step intermediate to be 1:0.5, but at the same time, because the molecular weight of the mPEG-SCM (monomethoxypolyethylene glycol succinimidyl acetate) used is difficult to determine precisely, it is almost impossible to control strictly the molar quantity ratio of the charges to 1:0.5, thereby making it difficult to achieve 100% conversion, and there are cases where a polymerization intermediate is present together with the raw material. Resulting in less than expected conversion of the intermediate when cut into finished products.
Disclosure of Invention
The invention aims to provide a preparation method of monomethoxy polyethylene glycol mercapto, which can achieve the intermediate conversion rate of nearly 100%, and adopts TCEP as a disulfide bond cutting reducing agent, so that the conversion rate is improved.
The invention provides a preparation method of monomethoxy polyethylene glycol sulfhydryl, which comprises the following steps:
step one: mixing and reacting cystamine hydrochloride, triethylamine and an ester compound of mPEG to obtain an SH intermediate;
step two: adding tris (2-carboxyethyl) phosphine (TCEP), the SH intermediate in the first step and 2, 6-di-tert-butyl-p-cresol (BHT) into a buffer solution for reaction to obtain monomethoxy polyethylene glycol sulfhydryl.
Preferably, the mass ratio of the cystamine hydrochloride, the triethylamine and the mPEG ester compound in the step one is (1-2): 6 (0.8-1).
Preferably, the ratio of the cystamine hydrochloride, triethylamine and mPEG esters in the step one is 1:6:1.
Preferably, the esters of mPEG in step one are mPEG-SCM, mPEG-SC or mPEG-SS.
Preferably, the reaction temperature in the first step is room temperature, and the reaction time is 2-4h.
Preferably, the solvent in the first reaction is methylene chloride.
Preferably, the mass ratio of SH intermediate, tris (2-carboxyethyl) phosphine and 2, 6-di-tert-butyl-p-cresol in step two is 1:1.1:0.233.
preferably, the reaction temperature in the second step is 25 ℃ at room temperature, and the reaction time is 1h.
Preferably, the buffer solution in the second step is an aqueous solution prepared by sodium dihydrogen phosphate and sodium dihydrogen phosphate.
The beneficial effects of the invention are that
The invention provides a preparation method of monomethoxy polyethylene glycol sulfhydryl, which comprises the steps of mixing excessive cystamine hydrochloride, triethylamine and mPEG ester compounds for reaction to obtain an SH intermediate; then adding TCEP, the SH intermediate and BHT into the buffer solution to react, thus obtaining the monomethoxy polyethylene glycol sulfhydryl. Compared with the prior art, the conversion rate of the ester compound of mPEG can be nearly 100% because the intermediate preparation is added with excessive cystamine hydrochloride, meanwhile, the disulfide bond cutting step is replaced by TCEP compared with the traditional DTT or mercaptoethanol cutting agent, and if the DTT is used as the cutting reducing agent in the prior art, the residual DTT in the product can react with the reagent DTNB added in the detection link to generate other byproduct substances, so that the authenticity of the detection data is influenced. However, this does not occur with TCEP; in addition, compared with DTT, TECP has stronger reducing capability and better selectivity. TCEP is more stable in both acidic and basic conditions, is itself not charged, does not affect subsequent experiments, is not only a highly effective disulfide reducing agent, but also does not need to be removed in some thiol crosslinking reactions.
The method has higher yield, does not need to react in an argon environment, and has simpler conditions; the intermediate target is selected to be a single-ended product, and the addition ratio of other raw materials can be adjusted to increase the conversion rate of SCM.
Drawings
FIG. 1 is a nuclear magnetic resonance spectrum of an intermediate of example 1;
FIG. 2 is a nuclear magnetic resonance spectrum of the finished product of example 1.
Detailed Description
The invention provides a preparation method of monomethoxy polyethylene glycol sulfhydryl, which comprises the following steps:
step one: weighing cystamine hydrochloride, preferably adding 5 times of solvent into a round bottom flask, stirring and dissolving, adding triethylamine oil bath, stirring, preferably at 25 ℃, for 1-2 hours, then adding an ester compound of mPEG, stirring and reacting, preferably at 25 ℃, for 1-2 hours, preferably performing G3 suction filtration on the obtained reaction liquid, performing rotary evaporation on the filtrate, precipitating the rotary evaporation liquid by using 20 times of MTBE, performing G2 suction filtration, and performing vacuum drying to obtain an SH intermediate; the solvent is preferably dichloromethane; the esters of mPEG are preferably mPEG-SCM (monomethoxy polyethylene glycol succinimidyl acetate), mPEG-SC (monomethoxy polyethylene glycol succinimidyl carbonate) or mPEG-SS (monomethoxy polyethylene glycol succinimidyl succinate), more preferably mPEG-SCM.
The ratio of the amount of the cystamine hydrochloride, the triethylamine and the mPEG ester compounds is preferably (1-2) 6 (0.8-1), more preferably 1:6:1; the single-ended intermediate preparation is added into excessive cystamine hydrochloride, so that the conversion rate of the ester compound of mPEG can be close to 100%. The reaction process of this step is as follows:
step two: adding TCEP into a buffer solution, stirring and dissolving (pH=4-5), adding ethanol into BHT, stirring and dissolving, adding the SH intermediate in the first step into the buffer solution, adding BHT ethanol, reacting, wherein the reaction temperature is preferably 25 ℃ at room temperature, the reaction time is preferably 1h, extracting, adding anhydrous sodium sulfate for drying, performing suction filtration on G3, precipitating filtrate by using MTBE, performing suction filtration on G2, and performing vacuum drying to obtain monomethoxy polyethylene glycol mercapto; the ratio of the amounts of the substances of the SH intermediate, TCEP and BHT is preferably 1:1.1:0.233; the buffer solution is preferably an aqueous solution of sodium dihydrogen phosphate and sodium dihydrogen phosphate with a pH of about 7, and the reaction process is as follows:
the invention is described in further detail below with reference to the specific examples, wherein the starting materials are commercially available.
Example 1
Preparation of intermediate 5g
The feeding ratio is as follows: SCM (5 k): cystamine hydrochloride: triethylamine = 1:1:6
Weighing 0.225G of cystamine hydrochloride in a 25ml round bottom flask, adding 5ml of dichloromethane, 0.835ml of triethylamine and stirring for 1h in a 25-DEG oil bath, adding 5G of mPEG-SCM after complete dissolution, reacting for 1h, filtering the reaction solution by G3 suction to remove salt generated in the reaction after the reaction is finished, precipitating by using 100ml of MTBE, filtering by G2 suction, and vacuum drying a filter cake to obtain the middle; the intermediate purity was 100%. The nuclear magnetic hydrogen spectrum is shown in figure 1. In FIG. 1 a-CH 2 -, b-CH adjacent to carbon-oxygen bond 2 -,c:-CH 3 d-CH close to Sulfur 2 -。
Preparation of finished product 5g
SH intermediate (5 k): TCEP: bht=1: 1.1:0.233
Preparing a buffer solution: 5 times of phosphate solution (about ph=7) was prepared and Na was weighed 2 HPO 4 0.5625g of NaH in 7.7875ml of water 2 PO 4 0.53125g, dissolved in 17.125ml water, the two solutions were mixed well.
To the buffer solution, 0.197g of TCEP was dissolved with stirring (ph=between 4 and 5), and 0.031g of bht was dissolved with stirring by adding 5ml of ethanol. Weighing 5g of intermediate, adding buffer solution, adding BHT ethanol, completely dissolving, performing timing reaction for 1h,stopping the reaction, extracting for 2 times with DCM, adding anhydrous sodium sulfate, drying for 30min, suction-filtering with G3, precipitating filtrate with MTBE, suction-filtering with G2, and vacuum-drying to obtain the final product. The purity of the finished product is 99 percent. The nuclear magnetic hydrogen spectrum is shown in figure 2. In FIG. 2, a-CH 2 -,b:CH 3 ,c:-SH。
Example 2
Preparation of intermediate 5g
The feeding ratio is as follows: SCM (5 k): cystamine hydrochloride: triethylamine = 1:1.5:6
0.3378G of cystamine hydrochloride is weighed into a 100ml round bottom flask, 50ml of dichloromethane, 0.835ml of triethylamine and 25 ℃ oil bath are added for stirring for 1h, 5G of SCM is added after complete dissolution, reaction is carried out for 1h, after the reaction is completed, the reaction solution is filtered by G3 suction to remove salt generated in the reaction, 200ml of MTBE is used for precipitation, G2 suction is used for filtration, and a filter cake is dried in vacuum to obtain an intermediate. The intermediate purity was 100%.
Preparation of finished product 5g
SH intermediate (5 k): TCEP: bht=1: 1.1:0.233
Preparing a buffer solution: 5 times the amount of phosphate solution (approximately ph=7) was prepared, 40.5625g of na2hpo was dissolved in 7.7875ml of water, 40.53125g of nah2po was dissolved in 17.125ml of water, and the two solutions were mixed well.
To the buffer solution, 0.197g of TCEP was dissolved with stirring (ph=between 4 and 5), and 0.031g of bht was dissolved with stirring by adding 5ml of ethanol. Weighing 5G of intermediate, adding buffer solution, adding BHT ethanol, completely dissolving, timing to react for 1h, stopping the reaction, extracting with DCM for 2 times, adding anhydrous sodium sulfate, drying for 30min, performing G3 suction filtration, precipitating filtrate with MTBE, performing G2 suction filtration, and vacuum drying to obtain the finished product. The purity of the finished product is 99 percent
Example 3
Preparation of intermediate 5g
The feeding ratio is as follows: SCM (5 k): cystamine hydrochloride: triethylamine = 1:2:6
Weighing 0.45G of cystamine hydrochloride into a 100ml round bottom flask, adding 50ml of dichloromethane, 0.835ml of triethylamine, stirring for 1h in a 25-DEG oil bath, adding 5G of SCM after complete dissolution, reacting for 1h, filtering the reaction solution by G3 suction to remove salt generated in the reaction after the reaction is finished, precipitating by using 200ml of MTBE, filtering by G2 suction, and vacuum drying a filter cake to obtain an intermediate. The intermediate purity was 100%.
Preparation of finished product 5g
SH intermediate (5 k): TCEP: bht=1: 1.1:0.233
Preparing a buffer solution: 5 times the amount of phosphate solution (approximately ph=7) was prepared, 40.5625g of na2hpo was dissolved in 7.7875ml of water, 40.53125g of nah2po was dissolved in 17.125ml of water, and the two solutions were mixed well.
To the buffer solution, 0.197g of TCEP was dissolved with stirring (ph=between 4 and 5), and 0.031g of bht was dissolved with stirring by adding 5ml of ethanol. Weighing 5G of intermediate, adding buffer solution, adding BHT ethanol, completely dissolving, timing to react for 1h, stopping the reaction, extracting with DCM for 2 times, adding anhydrous sodium sulfate, drying for 30min, performing G3 suction filtration, precipitating filtrate with MTBE, performing G2 suction filtration, and vacuum drying to obtain the finished product. The purity of the finished product is 99 percent
According to the results of the three examples, three excess feed ratios were achieved to 100% purity of the intermediate, analysis by synthesis, 1:1: the feed ratio of 6 saves raw materials, so that this ratio is selected to be most suitable.
Comparative example 1
Preparation of intermediate 5g
The feeding ratio is as follows: SCM (5 k): cystamine hydrochloride: triethylamine = 1:0.8:6
Weighing 0.18G of cystamine hydrochloride in a 25ml round bottom flask, adding 5ml of dichloromethane, 0.835ml of triethylamine and stirring for 1h in a 25-DEG oil bath, adding 5G of mPEG-SCM after complete dissolution, reacting for 1h, filtering the reaction solution by G3 suction to remove salt generated in the reaction after the reaction is finished, precipitating by using 100ml of MTBE, filtering by G2 suction, and vacuum drying a filter cake to obtain the middle; the intermediate purity was 79%.
Comparative example 2
Preparation of SH intermediate the same as in example 1
Preparation of finished product 5g
SH intermediate (5 k): DTT: bht=1: 1.1:0.233
Preparing a buffer solution: 5 times the amount of phosphate solution (approximately ph=7) was prepared, 40.5625g of na2hpo was dissolved in 7.7875ml of water, 40.53125g of nah2po was dissolved in 17.125ml of water, and the two solutions were mixed well.
To the buffer solution, 0.106g of DTT (dithiothreitol) was added and dissolved with stirring (ph=between 4 and 5), and 0.031g of BHT was added to 5ml of ethanol and dissolved with stirring. Weighing 5G of intermediate, adding buffer solution, adding BHT ethanol, completely dissolving, timing to react for 1h, stopping the reaction, extracting with DCM for 2 times, adding anhydrous sodium sulfate, drying for 30min, performing G3 suction filtration, precipitating filtrate with MTBE, performing G2 suction filtration, and vacuum drying to obtain the finished product. The purity of the finished product is 99 percent.

Claims (9)

1. A method for preparing a monomethoxy polyethylene glycol mercapto group, which is characterized by comprising the following steps:
step one: mixing and reacting cystamine hydrochloride, triethylamine and an ester compound of mPEG to obtain an SH intermediate;
step two: and (3) adding tri (2-carboxyethyl) phosphine, the SH intermediate in the first step and 2, 6-di-tert-butyl-p-cresol into a buffer solution to react to obtain the monomethoxy polyethylene glycol mercapto.
2. The method for preparing a monomethoxy polyethylene glycol mercapto group according to claim 1, wherein the mass ratio of the cystamine hydrochloride, triethylamine and mPEG ester compound in the step one is (1-2): 6 (0.8-1).
3. The method for preparing monomethoxy polyethylene glycol mercapto according to claim 1, wherein the mass ratio of the cystamine hydrochloride, triethylamine and mPEG ester compound in step one is 1:6:1.
4. The method for preparing a monomethoxy polyethylene glycol mercapto group according to claim 1, wherein the mPEG ester compound in the step one is mPEG-SCM, mPEG-SC or mPEG-SS.
5. The method for preparing the monomethoxy polyethylene glycol mercapto group according to claim 1, wherein the reaction temperature in the first step is room temperature and the reaction time is 2-4h.
6. The method for preparing a mercapto group of monomethoxy polyethylene glycol according to claim 1, wherein the solvent in the first step is methylene chloride.
7. The method for preparing the monomethoxy polyethylene glycol mercapto group according to claim 1, wherein the mass ratio of the SH intermediate, the tris (2-carboxyethyl) phosphine and the 2, 6-di-t-butyl-p-cresol in the second step is 1:1.1:0.233.
8. the method for preparing the monomethoxy polyethylene glycol mercapto group according to claim 1, wherein the reaction temperature in the second step is 25 ℃ at room temperature and the reaction time is 1h.
9. The method for preparing a monomethoxy polyethylene glycol mercapto group according to claim 1, wherein the buffer solution in the second step is an aqueous solution of sodium dihydrogen phosphate and sodium dihydrogen phosphate.
CN202310822761.4A 2023-07-06 2023-07-06 Preparation method of monomethoxy polyethylene glycol sulfhydryl Pending CN116769154A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310822761.4A CN116769154A (en) 2023-07-06 2023-07-06 Preparation method of monomethoxy polyethylene glycol sulfhydryl

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310822761.4A CN116769154A (en) 2023-07-06 2023-07-06 Preparation method of monomethoxy polyethylene glycol sulfhydryl

Publications (1)

Publication Number Publication Date
CN116769154A true CN116769154A (en) 2023-09-19

Family

ID=87989430

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310822761.4A Pending CN116769154A (en) 2023-07-06 2023-07-06 Preparation method of monomethoxy polyethylene glycol sulfhydryl

Country Status (1)

Country Link
CN (1) CN116769154A (en)

Similar Documents

Publication Publication Date Title
EP1470106B1 (en) Method of manufacturing an amorphous form of the hemi-calcium salt of (3r, 5r) 7- 3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yl]-3, 5-dihydroxyheptanoic acid (atorvastatin)
CN114315534A (en) Preparation method of dapagliflozin intermediate
CN111269145A (en) Preparation method of acetamidine hydrochloride
CN102775441A (en) Continuous production method of glyphosate synthetic liquid
CN111100178B (en) Preparation method of medicinal-grade cholesterol sodium sulfate
CN116769154A (en) Preparation method of monomethoxy polyethylene glycol sulfhydryl
US20110319608A1 (en) Process for preparing a mixed salt of glucosamine sulfate and an alkali metal chloride
EP3653718A2 (en) Method for recovering phosphoric acid from fermentation liquor or fermentation waste liquor, and reusing same
CN108997424B (en) Simple method for preparing fosfomycin trometamol
CN111471121A (en) Synthesis method of sugammadex dimer impurity
CN113045416B (en) Preparation method of (R) -3-hydroxybutyryl- (R) -3-hydroxybutyl ester
CN110002981B (en) Method for preparing pseudo ionone
JP2004511475A (en) Method for producing racemic thioctic acid
JP2008297221A (en) Method for producing brightener for plating
KR20190078267A (en) Manufacturing method for lithium phosphate
CN107512709B (en) Preparation method of triangular prism self-assembled bow-tie-shaped hydroxyl copper phosphate electrode material
JPS632270B2 (en)
CN111004160A (en) Preparation method of 2-mercaptoethyl-2-hydroxyethyl sulfide
EP0456799A1 (en) Improved method of preparing an intermediate for the manufacture of bambuterol.
JPH0531556B2 (en)
CN111187255B (en) Preparation method of dextro-ilaprazole potassium salt and preparation method of dextro-ilaprazole
US11578345B2 (en) Functionalised polysulphide synthesis method
EP0104974B1 (en) Process for producing derivatives of hydroxy-methylene diphosphonic acid
US20110105786A1 (en) Creatinol o-phosphate and synthesis method thereof
CA2008498C (en) Process for synthesizing vicinal aklanedithiols

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination